SEC Form D private-offering filing

Consano Bio, Inc.

Name: Consano Bio, Inc. - new SEC Form D private-offering filing, Burlington, MA
Published: 2026-03-20

A new SEC Form D private-offering notice from Burlington, MA, a $48,858,795 filer-stated offering target in Biotech. The source filing is one click away.

Consano Bio, Inc. site↗ Verified via SEC Form D

Clinical-stage biotechnology company developing C-1101, a multi-protein biologic therapy for chronic lumbosacral radiculopathy (sciatica) and other orthopedic pain conditions.

Filed 2026-03-20Filed to raise $48,858,795First money in 2026-03-06Raised so far $34,824,466HQ (as filed) Burlington, MASector Biotech ✓Stage (inferred) GrowthCall status Call-ready

Source linked the Form D on EDGAR↗Website verified consanobio.com↗Named in the filing 9 executives & directors

Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.